Results 161 to 170 of about 320,703 (320)

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

Leukemia, 2016
H. Hjorth-Hansen, J. Stentoft, Johan Richter, Perttu Koskenvesa, Martin Höglund, A. Dreimane, K. Porkka, Tobias Gedde-Dahl, B. Gjertsen, F. Gruber, L. Stenke, K. Eriksson, B. Markevärn, A. Lubking, H. Vestergaard, Lene Udby, O. Bjerrum, Inger Persson, S. Mustjoki, U. Olsson‐Strömberg   +19 more
semanticscholar   +1 more source

Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon. [PDF]

Hepatol Int
Dong J, Ren S, Wu P, Yu H, Meng X, Zhao J, Ye X, Huang Y, Yu Z, Zhang W, Zeng Y, Wang X, Gao H, Dang S, Li J, Zheng S, Chen X.   +16 more
europepmc   +1 more source

Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection. [PDF]

Acta Derm Venereol, 2023
Gosmann J, Stadler R, Quint KD, Gutzmer R, Vermeer MH.   +4 more
europepmc   +1 more source

The impact of JAK2^V617F variant allele frequency in MPN patients following PEGylated interferon alpha discontinuation. [PDF]

Br J Haematol
Brown R, Bennett R, Crean C, Hindley A, McGimpsey J, Cunningham N, Niblock A, McPherson S, Boyd K, Foy A, Graham C, Greenfield G, McMullin MF, Catherwood MA.   +13 more
europepmc   +1 more source

Quasispecies Heterogeneity within the E1/E2 Region as a Pretreatment Variable during Pegylated Interferon Therapy of Chronic Hepatitis C Virus Infection

, 2005
Thomas J. Chambers, Xiaofeng Fan, Deborah A. Droll, Edgardo Hembrador, Tiffany Slater, M W Nickells, Lynn B. Dustin, A DIBISCEGLIE   +7 more
openalex   +1 more source

Global policy and access to new hepatitis C therapies for people who inject drugs [PDF]

, 2015
Aspinall, Esther, Doyle, Joseph S., Gore, Charles, Hellard, Margaret E., Hutchinson, Sharon, Quinn, Brendan, Wiktor, Stefan   +6 more
core   +1 more source

Short-term pegylated interferon alpha in chronic HBV patients with ultra-low HBsAg: a retrospective study. [PDF]

Front Cell Infect Microbiol
Liu H, Gong H, Tan Z, Wu Y, Ran L, Mao Q, Deng G, Jiang L, Xia J.   +8 more
europepmc   +1 more source

Efficacy Of Biosimilar Pegylated Interferon Alpha 40 Kd (Peg Inf) In Chronic Hepatitis C Infection

, 2013
Ghias ul Hassan, Bilal Nasir, Israr Ul Haque, ShafiqAwan, Ghias Un NabiTayyab, S. Hassan Akhtar Bokhari, Khawar Saeed, Qazi Masroor   +7 more
openalex   +2 more sources

Early viral kinetics and treatment outcome in combination of high‐dose interferon induction vs. pegylated interferon plus ribavirin for naïve patients infected with hepatitis C virus of genotype 1b and high viral load [PDF]

, 2004
Akihito Tsubota, Yasuji Arase, Takashi Someya, Yoshiyuki Suzuki, Fumitaka Suzuki, Satoshi Saitoh, Kenji Ikeda, Norio Akuta, Tetsuya Hosaka, Masahiro Kobayashi, Hiromitsu Kumada   +10 more
openalex   +1 more source

Efficacy and predictors of pegylated-interferon in hepatitis B surface antigen seroclearance in immune active and inactive chronic hepatitis B patients. [PDF]

J Virus Erad
Han C, Jin L, Zhu M, Qin Q, Li G, Liu Z, Zhang X.   +6 more
europepmc   +1 more source